Welcome to LookChem.com Sign In|Join Free
  • or
C12H16N2O2 is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

1093095-07-8

Post Buying Request

1093095-07-8 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1093095-07-8 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1093095-07-8 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,9,3,0,9 and 5 respectively; the second part has 2 digits, 0 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 1093095-07:
(9*1)+(8*0)+(7*9)+(6*3)+(5*0)+(4*9)+(3*5)+(2*0)+(1*7)=148
148 % 10 = 8
So 1093095-07-8 is a valid CAS Registry Number.

1093095-07-8Downstream Products

1093095-07-8Relevant academic research and scientific papers

Secondary amines as coupling partners in direct catalytic asymmetric reductive amination

Wu, Zitong,Du, Shaozhi,Gao, Guorui,Yang, Wenkun,Yang, Xiongyu,Huang, Haizhou,Chang, Mingxin

, p. 4509 - 4514 (2019/04/29)

The secondary amine participating asymmetric reductive amination remains an unsolved problem in organic synthesis. Here we show for the first time that secondary amines are capable of effectively serving as N-sources in direct asymmetric reductive amination to afford corresponding tertiary chiral amines with the help of a selected additive set under mild conditions (0-25 °C). The applied chiral phosphoramidite ligands are readily prepared from BINOL and easily modified. Compared with common tertiary chiral amine synthetic methods, this procedure is much more concise and scalable, as exemplified by the facile synthesis of rivastigmine and N-methyl-1-phenylethanamine.

INDOLINONE DERIVATIVES AND THEIR USE IN TREATING DISEASE-STATES SUCH AS CANCER

-

Page/Page column 27, (2009/01/24)

The present invention encompasses compounds of general formula (1) wherein R1 to R4 are defined as in claim 1, which are suitable for the treatment of diseases characterised by excessive or abnormal cell proliferation, and their use for preparing a pharmaceutical composition having the above-mentioned properties.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 1093095-07-8